OMCL stock forecast
Our latest prediction for Omnicell, Inc.'s stock price was made on the Oct. 18, 2019 when the stock price was at 76.07$.
In the short term (2weeks), OMCL's stock price should outperform the market by 0.53%. During that period the price should oscillate between -4.37% and +4.34%.
In the medium term (3months), OMCL's stock price should outperform the market by 2.91%. During that period the price should oscillate between -10.07% and +13.62%.
Get email alertsAbout Omnicell, Inc.
Omnicell, Inc. engages in the provision of medication and supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions. It operates through Automation & Analytics and Medication Adherence segments. The Automation & Analytics segment designs, manufactures, and sells medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment develops, manufactures and sells solutions to assist patients in becoming and remaining adherent to their medication regimens. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.
At the moment the company generates 860M USD in revenues.
On its last earning announcement, the company reported a profit of 1.28$ per share.
The book value per share is 14.99$
Three months stock forecastOct. 18, 2019
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 860M | 48.30% | 75M | 8.69% | 54M | 1.28 | - | - | 42M | 14.99 | 158M | -60M | 98M |